Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.